Michael E. Tarnoff - 19 Jul 2023 Form 4 Insider Report for ANGIODYNAMICS INC (ANGO)

Role
Director
Signature
/s/ Stephen A. Trowbridge, Attorney in Fact
Issuer symbol
ANGO
Transactions as of
19 Jul 2023
Net transactions value
$0
Form type
4
Filing time
21 Jul 2023, 21:11:03 UTC
Previous filing
22 Jul 2022
Next filing
19 Jul 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANGO Common Stock Award $0 +17,041 +61% $0.000000 45,162 19 Jul 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The acquisition of 17,041 shares of common stock of AngioDynamics, Inc. ("AngioDynamics") represents 17,041 restricted stock units granted as regular annual compensation for service as a director of AngioDynamics. The restricted stock units immediately vested at the time of grant.